CAD$0.01 (vs. loss of CAD$0.048 in Q3 2023)

High Tide (CVE:HITI) Q3 2024 Results

Key Financial Results

• Revenue: CAD 131.7 million (up 5.9% compared to Q3 2023).

• Net income: CAD$717.0k (up from a CAD$3.57 million loss in Q3 2023).

• Profit margin: 0.5% (compared to net loss in Q3 2023).

• EPS: CAD$0.01 (vs. loss of CAD$0.048 in Q3 2023).

All numbers shown in the chart above are for the last 12 months (TTM)

High Tide’s Profit Insight

Revenues are forecast to grow at an average annual rate of 11% over the next two years, while in Canada the pharmaceutical industry is forecasting growth of 11%.

Efficiency Canadian pharmaceutical industry.

The company’s shares fell 2.7% from the previous week.

Risk analysis

Please note that the tide is rising 2 warning signs in our investment analysis that you should know about…

Have an opinion on this article? Concerned about the content? Contact us with us directly. You can also email us at editorial-team (at) simplywallst.com.

This Simply Wall St article is for general information purposes only. Our commentary is based solely on historical data and analyst forecasts, and is based on an objective methodology. Our articles are not intended to be financial advice. It is not a recommendation to buy or sell stocks and does not take into account your objectives or your financial situation. Our goal is to provide you with long-term, focused analysis based on fundamental data. Please note that our analysis may not reflect the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.